NeoGenomics, Inc. announced that on October 5, 2021, Douglas M. VanOort, the former Chief Executive Officer of NeoGenomics, Inc. and currently the Company's Executive Chairman and Chairman of the Board of Directors of the ompany, notified the Board of his voluntary decision to retire from the company and that in connection with his retirement he was tendering his resignation as Executive Chairman and Chairman of the Board of the company, effective October 7, 2021. Mr. VanOort will remain as a director on the Board but plans to retire as a member of the Board before the end of the year as the Board concludes an ongoing search process. Mr. VanOort's decision to retire and resign as Executive Chairman and Chairman of the Board was not the result of any dispute or disagreement with the company, the Company's management or the Board on any matter relating to the operations, policies or practices of the company. The company announced a transition in the leadership of its Board of Directors. Ms. Lynn A. Tetrault, former Lead Independent Director, has been appointed Non-executive Chair of the Board of Directors. Ms. Tetrault replaces Douglas M. VanOort who served as Chairman and CEO from 2009 through April 2021 and recently as Executive Chair of the NeoGenomics Board of Directors. As part of the transition, Mr. VanOort will be stepping down as Executive Chairman and plans to retire as a member of the Board of Directors before the end of the year as the Board concludes an ongoing search process.